Trial · NCT03036124
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Subjects Included in the Composite Endpoint of CV Death, Hospitalization Due to Heart Failure or Urgent Visit Due to Heart Failure. | Dapa 10 mg | 386 | Participants | ||
| Subjects Included in the Composite Endpoint of CV Death, Hospitalization Due to Heart Failure or Urgent Visit Due to Heart Failure. | Placebo | 502 | Participants | ||
| Subjects Included in the Composite Endpoint of CV Death or Hospitalization Due to Heart Failure. | Dapa 10 mg | 382 | Participants | ||
| Subjects Included in the Composite Endpoint of CV Death or Hospitalization Due to Heart Failure. | Placebo | 495 | Participants | ||
| Events Included in the Composite Endpoint of Recurrent Hospitalizations Due to Heart Failure and CV Death. | Dapa 10 mg | 567 | events | ||
| Events Included in the Composite Endpoint of Recurrent Hospitalizations Due to Heart Failure and CV Death. | Placebo | 742 | events | ||
| Change From Baseline in the KCCQ Total Symptom Score | Dapa 10 mg | 6.1 | Standard Deviation 18.6 | Scores on a scale | |
| Change From Baseline in the KCCQ Total Symptom Score | Placebo | 3.3 | Standard Deviation 19.2 | Scores on a scale | |
| Subjects Included in the Composite Endpoint of ≥50% Sustained Decline in eGFR, ESRD or Renal Death. | Dapa 10 mg | 28 | Participants | ||
| Subjects Included in the Composite Endpoint of ≥50% Sustained Decline in eGFR, ESRD or Renal Death. | Placebo | 39 | Participants | ||
| Subjects Included in the Endpoint of All-cause Mortality. | Dapa 10 mg | 276 | Participants | ||
| Subjects Included in the Endpoint of All-cause Mortality. | Placebo | 329 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03036124/results